VentriPoint Diagnostics (VPT.V) Stock Price
VentriPoint Diagnostics Price
Revenue has compounded at 1.2% per year over the past 14 years to 179,928.00 CAD. VentriPoint Diagnostics's net margin stands at -1,778.6%, up from -5,138.3% several years earlier.
VentriPoint Diagnostics stock price
VentriPoint Diagnostics business model & stock analysis
Frequently asked questions about VentriPoint Diagnostics
Converted at the current exchange rate, the VentriPoint Diagnostics share trades at 0.05 EUR (0.09 CAD).
The VentriPoint Diagnostics share (VPT.V) is listed on 4 stock exchanges, including: Toronto (VPT.V), Frankfurt (5V7.F), München (5V7.MU).
The revenue cannot currently be calculated for VentriPoint Diagnostics.
The profit cannot currently be calculated for VentriPoint Diagnostics.
The P/E ratio cannot be calculated for VentriPoint Diagnostics at the moment.
The P/S cannot be calculated for VentriPoint Diagnostics currently.
The Eulerpool Quality Score for VentriPoint Diagnostics is 4/10.
The ISIN of VentriPoint Diagnostics is CA92281P2008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of VentriPoint Diagnostics is A2ABKZ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of VentriPoint Diagnostics is VPT.V. The ticker symbol is used to trade VentriPoint Diagnostics shares on the stock exchange.
VentriPoint Diagnostics stock
VentriPoint Diagnostics Peer Group
VentriPoint Diagnostics Ticker
VentriPoint Diagnostics FIGI
All fundamentals and in-depth analysis of VentriPoint Diagnostics
Our stock analysis for VentriPoint Diagnostics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of VentriPoint Diagnostics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.